Kirkland, Wash.-based Cardiac Dimensions raised a $17.5 million Series C round. The company will use the fresh cash to help sell its heart-valve repair device.

Founded in 2001, the Seattle-area medical device startup has developed a way to address cardiovascular conditions with its Carillon Mitral Contour System, a non-surgical device that treats a form of congestive heart failure called mitral valve regurgitation, which affects how the heart properly pumps out blood.

The Series C round included existing investors such as Aperture Venture Partners, Arboretum Ventures, Hostplus, Life Sciences Partners, Lumira Ventures, and M. H. Carnegie & Co.

Like what you're reading? Subscribe to GeekWire's free newsletters to catch every headline

Job Listings on GeekWork

Find more jobs on GeekWork. Employers, post a job here.